ACCESS TO INSIGHT
|CORE FACULTY &
|CLINICAL RESEARCH GRANT||RECIPIENTS||CONTACT US|
The Access to Insight Basic Research Grant with a value of up to € 60,000 is for basic science or translational research relevant to the understanding of the pathophysiology and treatment of haemostatic disorders. The grant can be used to cover salary and/or project costs over a 12–18 month period.
The research priorities are the interactions of blood coagulation components (cells and proteins) and treatment of haemophilia. Topics could include the following:
In order to maintain a focus on interactions of blood coagulation components and haemophilia treatment, Access to Insight basic research grants will not support research focused on:
It is assumed that a maximum of 20% of the total grant can be assigned to the candidate’s institute as overhead costs.
The quality of the project idea is the main criterion for the proposal evaluation.
The conditions of the Access to Insight programme require that any additional funding for the same project from other sources (e.g. WFH, ISTH-SSC) be declared to both funding sources. We appreciate grant recipients’ cooperation in this regard.